|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.315 USD | -0.22% |
|
-1.70% | +28.33% |
| May. 13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| May. 13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 2026-06-29 | 2026-06-30 | 2026-07-01 | 2026-07-02 | 2026-07-06 | |
|---|---|---|---|---|---|
| Last | $2.350 | $2.330 | $2.300 | $2.320 | $2.310 |
| Volume | 540,557 | 500,098 | 436,234 | 472,793 | 238,081 |
| Change | +2.17% | -0.85% | -1.29% | +0.87% | -0.22% |
| Opening | $2.310 | $2.360 | $2.310 | $2.300 | $2.310 |
| High | $2.380 | $2.360 | $2.335 | $2.355 | $2.350 |
| Low | $2.255 | $2.310 | $2.260 | $2.270 | $2.295 |
Performance
| 1 day | -0.22% | ||
| 1 week | -1.70% | ||
| Current month | -0.86% | ||
| 1 month | +17.86% | ||
| 3 months | +4.52% | ||
| 6 months | +30.51% | ||
| Current year | +28.33% | ||
| 1 year | +57.14% | ||
| 3 years | +29.05% | ||
| 5 years | +29.05% | ||
| 10 years | -63.33% |
Volumes
marketsDaily volume
238,081
Estimated daily volume
315,732
Avg. Volume 20 sessions
769,377
Daily volume ratio
0.41
Avg. Volume 20 sessions USD
1,781,107.76
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
186,926,209
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
179,677,592
Average Daily Capital Traded
0.95%
Indicators
Moving average 5 days
2.32
Moving average 20 days
2.122
Moving average 50 days
2.082
Moving average 100 days
2.329
Price spread / (MMA5)
+0.22%
Price spread / (MMA20)
-8.34%
Price spread / (MMA50)
-10.06%
Price spread / (MMA100)
+0.60%
STIM
RSI 9 days
65.37
RSI 14 days
62.54
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | -1.70% | +57.14% | +29.05% | 187M | |
| -0.58% | -1.93% | +56.07% | +160.40% | 1,082B | |
| -1.78% | -0.14% | +66.26% | +59.75% | 633B | |
| -1.96% | +0.61% | +36.36% | +86.41% | 461B | |
| -2.79% | +1.37% | +31.00% | +23.05% | 338B | |
| -2.46% | -1.38% | +37.99% | +36.52% | 299B | |
| -2.20% | -0.87% | +28.16% | +42.69% | 291B | |
| -1.77% | +1.97% | -27.22% | -40.66% | 222B | |
| -2.06% | +1.28% | +24.65% | +63.76% | 202B | |
| -1.63% | +2.18% | +15.49% | +69.32% | 163B | |
| Average | -1.80% | +4.46% | +32.59% | +53.03% | 369.26B | |
| Weighted average by Cap. | -1.68% | +5.43% | +40.88% | +80.61% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
a4b7900ab1366b9.zjUq0tLtSAW22qQAyhmes3UPl4uaeEOX-pqqhv0QBxM.r1doh__aF23GsMJMlS2u3y975vOiEQXRjanYssQpXyaRA3u0nYR5QdqW9Q
| Date | Price | Volume | Total |
|---|---|---|---|
| 02:20:54 pm | 2.310 | 100 | 150,242 |
| 02:20:54 pm | 2.310 | 100 | 150,142 |
| 02:20:54 pm | 2.310 | 600 | 150,042 |
| 02:20:54 pm | 2.315 | 200 | 149,442 |
| 02:20:54 pm | 2.310 | 100 | 149,242 |
| 02:20:54 pm | 2.310 | 100 | 149,142 |
| 02:20:54 pm | 2.310 | 100 | 149,042 |
| 02:20:54 pm | 2.310 | 100 | 148,942 |
| 02:20:54 pm | 2.310 | 120 | 148,842 |
| 02:20:54 pm | 2.310 | 105 | 148,722 |
Course Extremes
| 1 week | 2.26 |  | 2.36 |
| 1 month | 1.94 | | 2.38 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.36 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +28.89% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
